Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions
NCT01570907
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Treatment for Bipolar I Disorder
Interventions
DRUG:
Quetiapine Fumarate
Sponsor
Roxane Laboratories